Share：
Share this content in WeChat
X
[Chinese][PDF]783125
• Review •
Progress in the application of magnetic resonance multi-sequence diagnosis to evaluate acute myocardial infarction
LI Xia  LIU Wenya 

Cite this article as: Li X, Liu WY. Progress in the application of magnetic resonance multi-sequence diagnosis to evaluate acute myocardial infarction. Chin J Magn Reson Imaging, 2019, 10(3): 214-217. DOI:10.12015/issn.1674-8034.2019.03.011.


[Abstract] Cardiovascular magnetic resonance technology provides a non-invasive method for understanding cardiac structure and function, with high diagnostic accuracy and no ionizing radiation. Delayed imaging with perfusion enhancement technology provides valuable diagnostic and prognostic information for myocardial infarction. However, the degree of myocardial infarction and diffuse changes in the heart cannot be accurately evaluated. T1 mapping technology is a new technique for quantitative assessment of myocardial limitations and diffuse lesions. It can quantitatively assess the extent of myocardial infarction and the area of myocardial edema. It has good diagnostic and prognostic value,it has better application prospects in clinical practices.
[Keywords] myocardial infarction；magnetic resonance imaging

LI Xia Imaging Center, the First Affiliated Hospital of Xinjiang Medical University, Urumqi 830054, China

LIU Wenya* Imaging Center, the First Affiliated Hospital of Xinjiang Medical University, Urumqi 830054, China

*Correspondence to: Liu WY, E-mail: 13999202977@163.com

Conflicts of interest   None.

ACKNOWLEDGMENTS  This review was supported by Natural Science Foundation of Youth Foundation of Xinjiang Uygur Autonomous Region No. 2017D01C352
Received  2018-11-08
Accepted  2019-01-21
DOI: 10.12015/issn.1674-8034.2019.03.011
Cite this article as: Li X, Liu WY. Progress in the application of magnetic resonance multi-sequence diagnosis to evaluate acute myocardial infarction. Chin J Magn Reson Imaging, 2019, 10(3): 214-217. DOI:10.12015/issn.1674-8034.2019.03.011.

[1]
Moran A, Gu D, Zhao D, et al. Future cardiovascular disease in China: markov model and risk factor scenario projections from the coronary heart disease policy model-China. Circ Cardiovasc Qual Outcomes, 2010, 3(3): 243-252.
[2]
Abdelaty H, Cocker M, Meek C, et al. Edema as a very early marker for acute myocardial ischemia: a cardiovascular magnetic resonance study.. Journal of the American College of Cardiology, 2009, 53(14): 1194-1201.
[3]
宋林声，赵蕾，赵新湘，等．心脏MRI评估心肌梗死病理变化的研究进展．中国医学影像技术, 2017, 33(12): 1893-1897.
[4]
Kidambi A, Biglands JD, Higgins DM, et al. Susceptibility-weighted cardiovascular magnetic resonance in comparison to T2 and T2 star imaging for detection of intramyocardial hemorrhage following acute myocardial infarction at 3 Tesla. J Cardiovasc Magn Reson, 2014, 16(1): 86-97.
[5]
Kandler D, Lücke C, Grothoff M, et al. The relation between hypointense core, microvascular obstruction and intramyocardial haemorrhage in acute reperfused myocardial infarction assessed by cardiac magnetic resonance imaging. Eur Radiol, 2014, 24(12): 3277-3288.
[6]
Garg P, Saunders LC, Swift AJ, et al. Role of cardiac T1 mapping and extracellular volume in the assessment of myocardial infarction. Anatol J Cardiol, 2018, 19: 404-411
[7]
陈秀玉，赵世华. 2017 SCMR心脏磁共振参数定量技术专家共识解读．磁共振成像, 2018, 9(5): 368-373.
[8]
Wuest W, Lell M, May M, et al. Determining microvascular obstruction and infarct size with steady-state precession imaging cardiac MRI. Plos One, 2015, 10(3), eo119788.
[9]
Kociemba A, Lanocha M, Katulska K, et al. Detection of myocardial oedema with the use of diffusion-weighted imaging in acute myocardial infarction. J Cardiovasc Magn Reson, 2011, 13(1): 1-2.
[10]
Ibrahim ES. Myocardial tagging by cardiovascular magnetic resonance: evolution of techniques: pulse sequences, analysis algorithms, and applications. J Cardiovasc Magn Reson, 2011, 13(1): 36.
[11]
Hombach V, Grebe O, Merkle N, et al. Sequelae of acute myocardial infarction regarding cardiac structure and function and their prognostic significance as assessed by magnetic resonance imaging. Eur Heart J, 2005, 26: 549-557.
[12]
Rehwald, WG. Myocardial magnetic resonance imaging contrast agent concentrations after reversible and irreversible ischemic injury. Circulation, 2002, 105(2): 224-229.
[13]
Garg P, Plein S. Native T1 mapping: adding a new dimension to the characterization of acute myocardial infarction. Circ Cardiovasc Imaging, 2017, 10(8): e006767.
[14]
Messroghli DR, Walters K, Plein S, et al. Myocardial T1 mapping: application to patients with acute and chronic myocardial infarction. Magn Reson Med, 2010, 58(1): 34-40.
[15]
Robbers LF, Eerenberg ES, Teunissen PF, et al. Magnetic resonance imaging-defined areas of microvascular obstruction after acute myocardial infarction represent microvascular destruction and haemorrhage. Eur Heart J, 2013, 34(30): 2346-2353.
[16]
张如志，陈伟，夏睿，等．心脏MR延迟强化在急性心肌梗死的应用及研究现状．国际医学放射学杂志, 2015, 38(1): 30-34.
[17]
Ridgway JP. Cardiovascular magnetic resonance physics for clinicians: part I. J Cardiovasc Magn Reson, 2010, 12(1): 1-28.
[18]
殷亮，喻思思，龚良庚．心脏磁共振纵向弛豫时间定量成像技术进展.中华放射学杂志, 2016, 50(1): 76-78.
[19]
Moon JC, Messroghli DR, Peter K, et al. Myocardial T1 mapping and extracellular volume quantification: a society for cardiovascular magnetic resonance (SCMR) and CMR Working Group of the European Society of Cardiology consensus statement. J Cardiovasc Magn Reson, 2013, 15(1): 92.
[20]
陆敏杰，赵世华，蒋世良，等. MR纵向弛豫时间定量成像评价肥厚型心肌病心肌纤维化的初步研究．中华放射学杂志, 2013, 47(5): 391-395.
[21]
谢佳均，刘辉. T1 mapping技术检测心肌弥漫性纤维化的临床应用进展．岭南心血管病杂志, 2016, 22(4): 487-490.
[22]
Dall'Armellina E, Piechnik SK, Ferreira VM, et al. Cardiovascular magnetic resonance by non contrast T1-mapping allows assessment of severity of injury in acute myocardial infarction. J Cardiovasc Magn Reson, 2012, 14: 15.
[23]
尹刚，贺光军，赵世华．心血管MRI第三部分：心血管磁共振临床应用概述．磁共振成像, 2013. 4(6): 450-458.
[24]
Cameron D, Siddiqi N, Neil CJ, et al. T1 mapping for assessment of myocardial injury and microvascular obstruction at one week post myocardial infarction. Eur J Radiol, 2016, 85(1): 279-285.
[25]
Ugander M, Oki AJ, Hsu LY, et al. Extracellular volume imaging by magnetic resonance imaging provides insights into overt and sub-clinical myocardial pathology. Eur Heart J, 2012, 33(10): 1268-1278.
[26]
Messroghli DR, Niendorf T, Schulz-Menger J, et al. T1 Mapping in patients with acute myocardial infarction. J Cardiovasc Magn Reson, 2003, 5(2): 353-359.
[27]
Liu A, Wijesurendra RS, Francis JM, et al. Adenosine stress and rest T1 mapping can differentiate between ischemic, infarcted, remote, and normal myocardium without the need for gadolinium contrast agents. Jacc Cardiovasc Imaging, 2016, 9(1): 27-36.
[28]
Dall"Armellina E, Ferreira VM, Kharbanda RK, et al. Diagnostic value of pre-contrast T1 mapping in acute and chronic myocardial infarction. JACC Cardiovasc Imaging, 2013, 6(6): 739-742.
[29]
Choi EY, Hwang SH, Yoon YW, et al. Correction with blood T1 is essential when measuring post-contrast myocardial T1 value in patients with acute myocardial infarction. J Cardiovasc Magn Reson, 2013, 15(1): 11-19.
[30]
刘明熙．磁共振T1、T2mapping技术定量评价心肌的初步研究．第四军医大学, 2015: 1-62.
[31]
祁丽，张龙江，卢光明．心肌磁共振T1 Mapping技术及其临床应用进展．医学研究生学报, 2015, 28(6): 650-655.
[32]
Kidambi A, Motwani M, Uddin A, et al. Myocardial extracellular volume estimation by CMR predicts functional recovery following acute myocardial infarction. J Cardiovasc Magn Reson, 2015, 17(1): 1-2.
[33]
Haaf P, Garg P, Messroghli DR, et al. Cardiac T1 mapping and extracellular volume (ECV) in clinical practice: a comprehensive review. J Cardiovasc Magn Reson, 2016, 18(1): 89-101.

PREV Gliosarcoma: a case report and its misdiagnosis analysis
NEXT Advances of functional magnetic resonance imaging in application of tumor treatment outcome after radiotherapy or chemotherapy
  


LINK


Tel & Fax: +8610-67113815    E-mail: editor@cjmri.cn